CMENasdaqSecurity & Commodity Brokers, Dealers, Exchanges & ServicesFiscal year ends December 31
CME GROUP INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 24, 2026
$293.53−0.34 (-0.12%)
Close on Oct 19, 2026
- Market cap
- $106.05B
- P/E (TTM)
- 24.9
- Dividend yield
- 1.70%
Margins
Share of revenue, fiscal years 2011 to 2025
Operating margin
64.9%+10.9 pts over 5 years
Net margin
62.5%+19.3 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +6.4% | +9.1% | +6.0% | +7.0% | |
| Operating income | +7.6% | +11.9% | +9.9% | +7.8% | |
| Net income | +15.5% | +14.8% | +14.1% | +12.6% | |
| EPS, diluted | +15.4% | +14.7% | +13.7% | +11.7% | |
| Free cash flow | +16.6% | +12.2% | +10.7% | +11.5% | |
| Dividend per share | -51.9% | -16.2% | -3.3% | +0.2% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 7.5% | 8.0% | 14.8% | |
| Return on assets | 2.2% | 2.1% | 2.4% | |
| Current ratio | 1.03 | 1.01 | 1.03 | |
| Capex to revenue | 2.6% | 4.0% | 1.3% | |
| Diluted shares | 339M | 359M | 360M |
Where the cash went
Fiscal 2021 to 2025, five years combined
CME generated $16.88B from operations and spent $16.05B on capital expenditure, dividends and share buybacks. 3% of that went back into the business.
Generated
$16.88B
Used
$16.05B
Capital expenditure$470.80M3%Dividends$15.58B97%Share buybacks$00%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin62.5%
×Asset turnover0.04×
×Equity multiplier6.08×
=Return on equity, FY202514.8%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 62.5% | 0.04× | 6.08× | 14.8% |
| FY2024 | 57.5% | 0.05× | 5.02× | 13.2% |
| FY2023 | 57.8% | 0.04× | 5.67× | 12.0% |
| FY2022 | 53.6% | 0.03× | 6.83× | 9.9% |
| FY2021 | 56.2% | 0.03× | 5.98× | 9.8% |
| FY2020 | 43.1% | 0.05× | 3.81× | 8.0% |
| FY2019 | 43.5% | 0.06× | 2.93× | 8.1% |
| FY2018 | 45.5% | 0.06× | 3.17× | 8.1% |
| FY2017 | 111.5% | 0.05× | 3.40× | 19.0% |
| FY2016 | 42.7% | 0.05× | 3.34× | 7.5% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
6of 7 tests passed in fiscal 2025. Some tests lack the figures they need.
- ProfitableNet income above zero$4.07B
- Cash generatingOperating cash flow above zero$4.28B
- Return on assets improvedROA up on the prior year2.7% → 3.0%
- Earnings backed by cashOperating cash flow above net income$4.28B vs $4.07B
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose1.01 → 1.03
- No dilutionShare count did not rise360M → 360M
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose0.05 → 0.05